Page 99 - Read Online

Ma et al. J Transl Genet Genom 2022;6:179-203 https://dx.doi.org/10.20517/jtgg.2021.48 Page 197

25. Jonas JB, Ohno-Matsui K, Spaide RF, Holbach L, Panda-Jonas S. Macular Bruch’s membrane defects and axial length: association
with gamma zone and delta zone in peripapillary region. Invest Ophthalmol Vis Sci 2013;54:1295-302. DOI PubMed
26. Yoshida T, Ohno-matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization. Ophthalmology 2003;110:1297-305. DOI
27. Yokoi T, Ohno-Matsui K. Diagnosis and treatment of myopic maculopathy. Asia Pac J Ophthalmol (Phila) 2018;7:415-21. DOI
28. Spaide RF. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol 1999;10:177-81. DOI PubMed
29. Ohno-Matsui K, Yoshida T, Futagami S, et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal
neovascularisation in pathological myopia. Br J Ophthalmol 2003;87:570-3. DOI PubMed PMC
30. Ikuno Y, Jo Y, Hamasaki T, Tano Y. Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol
Vis Sci 2010;51:3721-5. DOI PubMed
31. Farinha CL, Baltar AS, Nunes SG, et al. Progression of myopic maculopathy after treatment of choroidal neovascularization.
Ophthalmologica 2014;231:211-20. DOI PubMed
32. Hayashi K, Ohno-Matsui K, Yoshida T, et al. Characteristics of patients with a favorable natural course of myopic choroidal
neovascularization. Graefes Arch Clin Exp Ophthalmol 2005;243:13-9. DOI PubMed
33. Yoshida T, Ohno-matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia.
Ophthalmology 2002;109:712-9. DOI PubMed
34. Nagaoka N, Shimada N, Hayashi W, et al. Characteristics of periconus choroidal neovascularization in pathologic myopia. Am J
Ophthalmol 2011;152:420-427.e1. DOI PubMed
35. Lee DH, Kang HG, Lee SC, Kim M. Features of optical coherence tomography predictive of choroidal neovascularisation treatment
response in pathological myopia in association with fluorescein angiography. Br J Ophthalmol 2018;102:238-42. DOI PubMed
36. Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL. Natural history of choroidal neovascularization in degenerative
myopia. Ophthalmology 1984;91:1573-81. DOI PubMed
37. Kojima A, Ohno-Matsui K, Teramukai S, et al. Estimation of visual outcome without treatment in patients with subfoveal choroidal
neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 2006;244:1474-9. DOI PubMed
38. Bottoni F, Tilanus M.
International Ophthalmology;24:249-55. DOI PubMed
39. Neelam K, Cheung CM, Ohno-Matsui K, Lai TY, Wong TY. Choroidal neovascularization in pathological myopia. Prog Retin Eye
Res 2012;31:495-525. DOI PubMed
40. Mcbrien N. Role of the sclera in the development and pathological complications of myopia. Progress in Retinal and Eye Research
2003;22:307-38. DOI PubMed
41. Ohno-Matsui K, Akiba M, Ishibashi T, Moriyama M. Observations of vascular structures within and posterior to sclera in eyes with
pathologic myopia by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53:7290-8. DOI PubMed
42. Moriyama M, Ohno-Matsui K, Futagami S, et al. Morphology and long-term changes of choroidal vascular structure in highly
myopic eyes with and without posterior staphyloma. Ophthalmology 2007;114:1755-62. DOI PubMed
43. Ishida T, Watanabe T, Yokoi T, Shinohara K, Ohno-Matsui K. Possible connection of short posterior ciliary arteries to choroidal
neovascularisations in eyes with pathologic myopia. Br J Ophthalmol 2019;103:457-62. DOI PubMed
44. Xie J, Chen Q, Yu J, et al. Morphologic features of myopic choroidal neovascularization in pathologic myopia on swept-source
optical coherence tomography. Front Med (Lausanne) 2020;7:615902. DOI PubMed PMC
45. Giuffrè C, Querques L, Carnevali A, De Vitis LA, Bandello F, Querques G. Choroidal neovascularization and coincident perforating
scleral vessels in pathologic myopia. Eur J Ophthalmol 2017;27:e39-45. DOI PubMed
46. Querques G, Corvi F, Balaratnasingam C, et al. Lacquer cracks and perforating scleral vessels in pathologic myopia: a possible causal
relationship. Am J Ophthalmol 2015;160:759-66.e2. DOI PubMed
47. Wakabayashi T, Ikuno Y, Oshima Y, Hamasaki T, Nishida K. Aqueous concentrations of vascular endothelial growth factor in eyes
with high myopia with and without choroidal neovascularization. J Ophthalmol 2013;2013:257381. DOI PubMed PMC
48. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76. DOI PubMed
49. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol
2006;39:469-78. DOI PubMed
50. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB j 1999;13:9-
22. PubMed
51. Seko Y, Seko Y, Fujikura H, et al. Induction of vascular endothelial growth factor after application of mechanical stress to retinal
pigment epithelium of the rat in vitro. Invest Ophthalmol Vis Sci 1999;40:3287-91. PubMed
52. Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M. Vascular endothelial growth factor in the aqueous humour in eyes with
myopic choroidal neovascularization. Acta Ophthalmol 2011;89:459-62. DOI PubMed
53. Costagliola C, Semeraro F, dell'Omo R, et al. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of
vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation. Br J
Ophthalmol 2015;99:1004-8. DOI PubMed
54. Ohno-Matsui K, Morita I, Tombran-Tink J, et al. Novel mechanism for age-related macular degeneration: an equilibrium shift
between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001;189:323-33. DOI PubMed
55. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA. An essential role for RPE-derived soluble VEGF in the
maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 2009;106:18751-6. DOI PubMed PMC